Glad you agree with something I have posted. Was starting to get worried u were just aimlessly downramping. I would be careful shorting, CfDing SRX, quarterly dose sales, if they r believable and they were curiously suspended prior to clinical trial observations, indicate a FV of about $26-28 for this stock. Again, if you believe the company, perhaps it is the medical research version of Enron? Previously the SRX history and governance was good prior to the new year and about a $30 SP.
a massive sell off, page-76
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)